tiprankstipranks

Gmbh Baxalta Insider Profile

4 Followers
Gmbh Baxalta, Ten Percent Owner at Onconova Therapeutics, holds 2.60M shares in Onconova Therapeutics (Ticker: ONTX). Most recently, Gmbh Baxalta Bought $2,603,295 shares of Onconova Therapeutics on May 08, 2015 for an estimated value of ―.
tipranks
Gmbh Baxalta

Gmbh Baxalta
Onconova Therapeutics (ONTX)
Ten Percent Owner

Not Ranked
Gmbh Baxalta has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$677K
100.00%
A breakdown of Gmbh Baxalta's holdings

Insider Roles

Onconova Therapeutics
(ONTX)
Ten Percent Owner
Roles that Gmbh Baxalta holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Gmbh Baxalta

Gmbh Baxalta's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Onconova Therapeutics
May 08, 2015
Ten Percent Owner
Informative Buy
$676.86K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 08, 2015
Informative Buy
-
$361.50
List of latest transactions for each holding click on a transaction to see Gmbh Baxalta's performance on stock

Gmbh Baxalta insider profile FAQ

What is the percentage of profitable transactions made by Gmbh Baxalta?
The percentage of profitable transactions made by Gmbh Baxalta is ―.
    What is the average return per transaction made by Gmbh Baxalta?
    The average return per transaction made by Gmbh Baxalta is ―.
      What stocks does Gmbh Baxalta hold?
      Gmbh Baxalta holds: ONTX stocks.
        What was Gmbh Baxalta’s latest transaction?
        Gmbh Baxalta latest transaction was an Informative Buy of ―.
          What was Gmbh Baxalta's most profitable transaction?
          Gmbh Baxalta’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Gmbh Baxalta's role in Onconova Therapeutics?
            Gmbh Baxalta's role in Onconova Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.